US clears first drug for tardive dyskinesia

12th April 2017 Uncategorised 0

Neurocrine Biosciences’ Ingrezza has become the first drug approved to treat the hyperkinetic movement disorder tardive dyskinesia in the US.

More: US clears first drug for tardive dyskinesia
Source: News